Counterfeit pharmaceuticals are a growing public health threat, with fentanyl-laced counterfeit pharmaceuticals contributing dangerously to the ongoing opioid crisis. Molecular analytical advancements are vital for the rapid, precise identification and regulation of counterfeit products. ...
Bluesight, the leading provider of inventory management, procurement, and compliance solutions for health systems and hospital pharmacies, today announced the acquisition of Protenus, provider of the leading healthcare compliance analytics platform. This strategic acquisition will further...
Discover how AI-powered wearable cameras detect and prevent medication errors in real-time, enhancing patient safety and reducing hospital costs. Read Article #NewTechnology
We Are a 501(c)(3)
Federal Tax ID: 52-1660752
DUNS Number: 073539913
1810 York Rd #435Lutherville, MD21093
Contactinfo@naddi.org
Corporate MembershipLearn MoreLogin/Join Us
Terms of UseCancellation/Refund PolicyCode of ConductCopyright PolicyPrivacy PolicyTrademark Policy